Receptor activator of nuclear factor kappa-B (RANK) is a crucial protein involved in the regulation of bone metabolism, immune response, and lymph node development by acting as a receptor for RANK ligand (RANKL). Its activation leads to osteoclast differentiation and activation, making it a target for therapeutic interventions in conditions like osteoporosis and cancer-induced bone diseases.
Receptor activator of nuclear factor kappa-B ligand (RANKL) is a crucial protein involved in the regulation of bone metabolism, primarily by promoting the differentiation and activation of osteoclasts, which are cells responsible for bone resorption. Dysregulation of RANKL activity is implicated in various bone disorders, such as osteoporosis and rheumatoid arthritis, making it a target for therapeutic interventions.